You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphoid hematological malignancies

Showing 1 - 25 of 4,520
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 22, 2023

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 20, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Dec 13, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Nutritional Supplement Drink
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Blood Clots and Bleeding in Hematological Malignancies, HAT

Recruiting
  • Acute Leukemia
  • +7 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jun 17, 2022

Biological Samples From Patients Treated With CAR-T Cells for

Recruiting
  • Lymphoma and Acute Lymphoblastic Leukemia
  • additional biological samples during CAR-T CELL treatment
  • Montpellier, France
    Département d'hématologie clinique
Dec 21, 2021

T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +4 more
  • anti-CD7 CAR-T cells
  • Shanghai, China
    Xianmin General Song
Aug 29, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +11 more
  • Zilovertamab vedotin
  • Duarte, California
  • +13 more
Jan 12, 2023

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)

Recruiting
  • Neoplasm, Plasma Cell
  • Lymphoma
  • Comprehensive Geriatric Assessment
  • Toulouse, France
    University Hospital Toulouse
Oct 12, 2022

Relapsed and Refractory, Lymphoid Hematological Malignancies Trial in Hangzhou (CD20/CD22 dual Targeted CAR T-cells)

Recruiting
  • Relapsed and Refractory
  • Lymphoid Hematological Malignancies
  • CD20/CD22 dual Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 20, 2020

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)

    Recruiting
    • Cytokine Release Syndrome
    • +4 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 17, 2021

    MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

    Recruiting
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
    • +8 more
      • Boston, Massachusetts
      • +6 more
      Apr 14, 2022

      Hematologic Malignancy Trial in Tianjin (BR108 injection)

      Recruiting
      • Hematologic Malignancy
      • BR108 injection
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Aug 25, 2023

      Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia in Remission
      • +10 more
      • CliniMACS
      • Houston, Texas
      • +1 more
      Dec 8, 2022

      T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

      Recruiting
      • T-cell Acute Lymphoblastic Leukemia
      • +3 more
      • Universal CD7-specific CAR gene-engineered T cells
      • Beijing, Beijing, China
      • +2 more
      Aug 17, 2023

      Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

      Not yet recruiting
      • Non-hodgkin's Lymphoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Sep 27, 2023

      Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

      Recruiting
      • Hematologic Malignancy
      • Myeloid Malignancy
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Nov 7, 2022

      Acute Lymphoblastic Leukemia, Chronic Lymphoblastic Leukemia, B-cell Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide +

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
      • Wuhan, Hubei, China
      • +1 more
      Mar 11, 2021

      Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

      Not yet recruiting
      • Hematological Malignancies
      • "Blend of ginger and lemon essential oils", "Neutral oil"
      • Limoges, France
        University Hospital, Limoges
      Nov 20, 2023

      Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

      Enrolling by invitation
      • Monoclonal Gammopathy of Undetermined Significance
      • +6 more
        • Milwaukee, Wisconsin
          Aurora Health Care
        Jul 20, 2021